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Vascular Medicine
Vasoconstrictor Reserve and Sympathetic Neural
Control of Orthostasis
Qi Fu, MD, PhD; Sarah Witkowski, MS; Benjamin D. Levine, MD
Background—We tested the hypothesis that individual variability in orthostatic tolerance is dependent on the degree of
neural and vasomotor reserve available for vasoconstriction.
Methods and Results—Muscle sympathetic nerve activity (MSNA) and hemodynamics were measured in 12 healthy
young volunteers during 60° head-up tilt (HUT), followed by a cold pressor test (CPT) in HUT. Orthostatic tolerance
was determined by progressive lower-body negative pressure (LBNP) to presyncope. The same protocols were
performed randomly in normovolemic and hypovolemic conditions. We found that mean arterial pressure increased and
stroke volume decreased, whereas heart rate (HR), MSNA, and total peripheral resistance (TPR) increased during HUT
(all P⬍0.01). Application of the CPT in HUT did not increase HR or decrease stroke volume further but elevated mean
arterial pressure (P⬍0.01) and increased MSNA and TPR in some subjects. There was a positive correlation between
the time to presyncope from ⫺50 mm Hg LBNP (equivalent to 60° HUT alone) and the changes in MSNA produced
by the CPT under both conditions (r⫽0.442, P⫽0.039). Those who had greater increases in MSNA had greater increases
in TPR during the CPT and longer time to presyncope (both P⬍0.05). One subject had dramatic increases in MSNA
but small increases in TPR during the CPT, which indicates a disassociation between sympathetic activity and the
increase in peripheral vascular resistance.
Conclusions—These results support our hypothesis and suggest that vasoconstrictor capability is a contributor to
orthostatic tolerance in humans. Vasoconstrictor reserve therefore may be one mechanism underlying individual
variability in orthostatic intolerance. (Circulation. 2004;110:2931-2937.)
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O

rthostatic intolerance is a common clinical problem that
occurs in patients with autonomic dysfunction. It may
also occur in healthy individuals, such as endurance athletes,1,2 astronauts returning from space,3 or after a period of
bed rest.4,5 However, the individual variability in the development of orthostatic intolerance is large, and the underlying
mechanisms remain unclear.
Normally, orthostatic stress evokes compensatory vasoconstriction in skeletal muscle via an increase in sympathetic
nerve traffic, which can be recorded as muscle sympathetic
nerve activity (MSNA) in humans.6 – 8 When this compensatory mechanism fails, arterial pressure will drop, and syncope
may occur.6,8,9 A progressive withdrawal of MSNA before
vasovagal syncope was observed in previous studies6,10,11; it
was thereby assumed that a reduced sympathetic activity
might play a causal role in orthostatic intolerance.10 On the
other hand, one study by Levine et al12 showed that MSNA
increased appropriately during upright tilt, but without a
commensurate increase in peripheral vascular resistance in

most astronauts returning from a 16-day space shuttle mission. A dissociation between the sympathetic activity and the
increase in vascular resistance could also be a mechanism that
explains the orthostatic intolerance after microgravity exposure or, more broadly, after cardiovascular deconditioning in
general.
We speculate that each human individual may have a finite
range of maximal vascular resistance that can be mediated by
adrenergic activity. A limited vasoconstrictor reserve may
result in reduced orthostatic tolerance, and orthostatic intolerance during hypovolemia may be a direct function of the
capacity for vasoconstrictor reserve. It is likely that the
vasoconstrictor reserve significantly affects the maintenance
of orthostatic tolerance.13,14 However, these speculations have
not yet been proven.
The purpose of this study was to test the hypothesis that
individual variability in orthostatic tolerance is dependent on
the degree of neural and vasomotor reserve available for
vasoconstriction. To accomplish this objective, we measured
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the amount of additional adrenergic activity and vasoconstriction that could be made available during orthostatic stress and
determined the relationship between the vasoconstrictor reserve and orthostatic tolerance in healthy individuals under
both normovolemic and hypovolemic conditions.

Methods
Subjects
Twelve healthy volunteers (7 men and 5 women; 28.3⫾1.7
[mean⫾SE] years old, 67.5⫾2.6 kg body weight, and 175.7⫾2.0 cm
in height) participated. No subject smoked, used recreational drugs,
or had significant medical problems. None was an endurance-trained
athlete.1 No woman was pregnant during the experiment. All
subjects gave their written informed consent, approved by the
Institutional Review Boards of the University of Texas Southwestern
Medical Center at Dallas and Presbyterian Hospital of Dallas.

Measurements
Heart Rate and Blood Pressure
Heart rate (HR) was monitored from the ECG (Hewlett-Packard),
and beat-to-beat arterial pressure was derived by finger photoplethysmography (Finapres, Ohmeda). Cuff blood pressure (BP) was
measured by electrosphygmomanometry (model 4240, Suntech),
with a microphone placed over the brachial artery to detect Korotkoff
sounds. Respiratory excursions were detected by a nasal cannula.

Cardiac Output
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Cardiac output was measured with the acetylene rebreathing technique.15 Cardiac output is calculated from the disappearance rate of
acetylene in expired air, measured with a mass spectrometer (model
MGA1100, Marquette), after adequate mixing in the lung has been
confirmed by a stable helium concentration. This method has been
validated against standard invasive techniques, including thermodilution and direct Fick at rest, during exercise and changes in
orthostatic stress, with a typical error (expressed as coefficient of
variation) of 4% to 5%.16 This method has been used extensively in
our laboratory and others,1,2,5,12,15,17 and it has been reviewed
recently in detail.18
Stroke volume (SV) was calculated from cardiac output and the
HR measured during rebreathing. Total peripheral resistance (TPR)
was calculated as the quotient of mean arterial pressure and cardiac
output, multiplied by 80 (expressed as dyne · s · cm⫺5). Mean arterial
pressure was calculated as [(SBP⫺DBP)/3]⫹DBP, where SBP and
DBP are cuff systolic and diastolic BP measured during rebreathing,
respectively.

(100⫺Hct1)]⫻[100(Hct1⫺Hct2]/Hct2]%, where Hct1 and Hct2 are
original and final hematocrit, respectively.

Acute Hypovolemia
Plasma volume was reduced with the administration of 20 mg of
furosemide. This dosage was chosen because it induced a reduction
in plasma volume of 7% to 14% after administration for ⬇2 hours,
equivalent to the loss of plasma volume observed after 2 weeks of
head-down bed rest.17,22 An oral potassium supplement of 20 mEq
was given before the injection of furosemide. After injection, urine
was collected and cuff BP was measured every 15 minutes. Approximately 2 hours later, the following protocols were performed.

Protocols
The experiment was performed in the morning ⱖ2 hours after a light
breakfast and ⱖ12 hours after the last caffeinated or alcoholic
beverage in a quiet, environmentally controlled laboratory with an
ambient temperature of ⬇25°C. The same protocols were performed
randomly in the normovolemic and hypovolemic conditions with an
⬇4-week interval, and therefore, females were in the same phases of
their menstrual cycles each time.

Protocol to Measure Vasoconstrictor Reserve

After ⱖ30 minutes of quiet rest in the supine position, baseline data
were collected for 6 minutes. The subject was then tilted passively to
a 60° head-up tilt (HUT) for 6 minutes, followed by a cold pressor
test (CPT) during tilting for another 3 minutes. A belt was placed
across the subject’s waist to make sure he or she would not fall. The
subject supported the body weight by standing on a plate at the end
of the tilt bed on one leg, allowing the other leg to be relaxed for
microneurography. The CPT was performed by immersing the
subject’s hand into an ice-water bath (⬇4°C). Subjects were instructed to avoid breath holding during the CPT. After that, the
subject was returned to the supine position for recovery.
HR, BP, respiratory waves, and MSNA were recorded continuously. Cardiac output was measured and a blood sample was taken
when supine, at the sixth minute of tilting, and at the third minute of
the CPT. After completion of this protocol, the microneurography
electrodes and intravenous catheter were removed.

Protocol for Maximal Orthostatic Tolerance Test

MSNA signals were obtained with the microneurographic technique.19 Briefly, a recording electrode was placed in the peroneal
nerve at the popliteal fossa, and a reference electrode was placed
subcutaneously 2 to 3 cm from the recording electrode. The nerve
signals were amplified (gain 70 000 to 160 000), band-pass filtered
(700 to 2000 Hz), full-wave rectified, and integrated with a
resistance-capacitance circuit (time constant 0.1 second). Criteria for
adequate MSNA recording included the following: (1) pulse synchrony; (2) facilitation during the hypotensive phase of the Valsalva
maneuver, and suppression during the hypertensive overshoot after
release; (3) increases in response to breath holding; and (4) insensitivity to emotional stimuli.19

After a sufficient recovery period (ⱖ20 minutes), the subject was
placed in the supine position in a Plexiglas lower-body negative
pressure (LBNP) tank sealed at the iliac crest level. Suction was
provided by a vacuum pump and controlled with a variable autotransformer calibrated against a mercury manometer. After ⱖ30
minutes of quiet rest, baseline measurements were repeated to
confirm a return to the hemodynamic steady state. Maximal orthostatic tolerance was determined by the use of progressive LBNP to
presyncope. LBNP was begun at ⫺15 mm Hg for 5 minutes, then
increased to ⫺30 and ⫺40 mm Hg for 5 minutes each, followed by
an increase in LBNP by ⫺10 mm Hg every 3 minutes until
presyncope was achieved. Presyncope was defined as a decrease in
systolic BP to ⬍80 mm Hg; a decrease in systolic BP to ⬍90 mm Hg
associated with symptoms of lightheadedness, nausea, sweating, or
diaphoresis; or progressive symptoms of presyncope accompanied
by a request from the subject to discontinue the test.2 A true
hypotensive end point was reached in all subjects in this study. The
recovery lasted for 5 minutes. A cumulative stress index was
calculated by adding the product of negative pressure and duration at
each level of LBNP and was used as a continuous measure of
orthostatic tolerance.

Blood Samples

Data Analysis

Blood samples were drawn from an intravenous catheter placed in
the antecubital vein. Plasma catecholamine was measured with
high-precision liquid chromatography.20 Hematocrit was determined
with a microcentrifuge. The percentage change in plasma volume
(⌬PV%) with administration of a diuretic (furosemide) in the
hypovolemic condition was estimated from hematocrit according to
the method described by Van Beaumont,21 namely, ⌬PV%⫽[100/

MSNA signals were identified by a computer program23 and confirmed by an experienced microneurographer. The number of bursts
per minute (burst frequency), the number of bursts per 100 heartbeats
(burst incidence), and the sum of the integrated burst area per minute
(total activity) were used as quantitative indexes. Because the
amplitude of bursts of sympathetic activity depends critically on
electrode position, whereas determinations of burst frequency are

Muscle Sympathetic Nerve Activity
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Hemodynamics and Orthostatic Tolerance in Normovolemic and
Hypovolemic Conditions
Hypovolemia

Normovolemia

Before
Furosemide

After
Furosemide

Body weight, kg

67.5⫾2.6

68.3⫾2.7

66.7⫾2.5*

Systolic BP, mm Hg

113⫾3

111⫾3

112⫾2

Diastolic BP, mm Hg

61⫾2

61⫾1

Cardiac output, L/min

7.54⫾0.56

7.32⫾0.64

5.53⫾0.35*‡

Norepinephrine, pg/mL

246.8⫾20.7*†

Variables

63⫾2

194.8⫾19.2

180.5⫾14.0

Epinephrine, pg/mL

18.8⫾3.7

14.4⫾1.9

15.5⫾2.9

Hematocrit, %

40.3⫾1.2

39.7⫾1.2

43.1⫾1.2*‡

Orthostatic tolerance
CSI, mm Hg⫻min

835⫾71

722⫾95

Time to presyncope, s

413⫾61

274⫾108

CSI indicates cumulative stress index. Values are mean⫾SE.
*P⬍0.01 vs before administration of furosemide.
†P⬍0.05 and ‡P⬍0.01 vs normovolemic condition.
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stable between recording sessions,24 total activity was normalized to
the resting supine value to allow comparisons between normovolemic and hypovolemic conditions. Therefore, the supine baseline
recording was assigned a value of 100%, and subsequent changes of
total activity were expressed as percentages of this baseline value.
HR, BP, and MSNA were averaged for 6 minutes during supine
baseline. Data were collected from the third to the fifth minute
during HUT and were averaged for 3 minutes. During the CPT, data
were collected during the initial 2 minutes and averaged for every 0.5
minute, and the highest value was used.

Statistical Analysis
Data are presented as mean⫾SE. Comparisons at baseline and LBNP
tolerance between normovolemic and hypovolemic conditions were
made with paired t tests. Changes in MSNA and hemodynamics due
to HUT and the CPT in HUT under both conditions were analyzed
with 2-way repeated-measures ANOVA, with Bonferroni method
post hoc for multiple comparisons. The relationship between the time
to presyncope from ⫺50 mm Hg LBNP (equivalent to 60° HUT
alone) during the orthostatic tolerance test and the changes in MSNA
produced by the CPT under both conditions were determined by
linear regression analysis. All statistical analyses were performed
with a personal computer– based analysis program (SigmaStat,
SPSS). A probability value of ⬍0.05 was considered statistically
significant.

Results
Supine Resting Values
Furosemide induced a diuresis of 1.6⫾0.1 L of urine volume
and increased hematocrit (Table; P⬍0.01), which resulted in
a 10.9⫾1.3% reduction in plasma volume. Mean arterial
pressure and HR did not change, but SV decreased (P⬍0.01)
in the hypovolemic condition (Figure 1). MSNA burst frequency (Figures 2 and 3) and burst incidence (19.6⫾2.7
bursts/100 heartbeats in normovolemia versus 26.4⫾3.2 in
hypovolemia), plasma norepinephrine (Table), and TPR (Figure 4) increased in the hypovolemic condition (all P⬍0.05).
Maximal LBNP tolerance tended to decrease in the hypovolemic compared with the normovolemic condition (Table;
P⫽0.129 and 0.135 for the cumulative stress index and the
time to presyncope).

Figure 1. Mean arterial pressure (MAP; A), HR (B), and stroke
volume (C) in response to 60° HUT and CPT during tilting
(CPT⫹HUT) in normovolemic and hypovolemic conditions. Values are mean⫾SE. **P⬍0.01 compared with supine; ##P⬍0.01
compared with normovolemia.

Hemodynamic and MSNA Responses to HUT
Mean arterial pressure and HR increased, whereas SV decreased during HUT (Figure 1; all P⬍0.01). HR was higher
and SV lower in the hypovolemic than in the normovolemic
condition (both P⬍0.01). MSNA increased during HUT, and
burst frequency was greater (Figure 3; P⬍0.01), whereas
burst incidence tended to be greater in the hypovolemic than
in the normovolemic condition (42.6⫾4.4 versus 36.7⫾3.1
bursts/100 heartbeats, P⫽0.108). However, normalized total
activity was not different between conditions during HUT
(435⫾68% in normovolemia versus 387⫾62% in hypovolemia, P⫽0.297). TPR increased during HUT under both
conditions (Figure 4; P⬍0.05).

Hemodynamic and MSNA Responses to CPT
During HUT
Application of the CPT in upright tilt elevated mean arterial
pressure (Figure 1A; P⬍0.01) but did not increase HR or
decrease SV further (Figure 1). HR was higher and SV lower
during the CPT in the hypovolemic condition than in the
normovolemic condition (Figures 1B and 1C; both P⬍0.01).
MSNA and TPR increased in some subjects during the CPT
under both conditions (Figures 3 and 4). There was a
significant positive correlation between the time to presyncope from ⫺50 mm Hg LBNP (equivalent to 60° HUT alone)
during the orthostatic tolerance test and the changes in
MSNA produced by the CPT under both conditions (Figure 5;
r⫽0.442, P⫽0.039). Those who had greater increases in
MSNA also had greater increases in TPR during the CPT and
longer time to presyncope during progressive LBNP (Figure
6; both P⬍0.05).
For some subjects, MSNA and/or TPR during the CPT in
upright tilt under the normovolemic condition appeared to be
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Figure 2. Original tracings of MSNA of 1
typical subject in supine position, at 60°
HUT, and during CPT⫹HUT under both
normovolemic and hypovolemic
conditions.
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maximal; in these subjects, MSNA/TPR during hypovolemic
tilt was equivalent to this maximal value and did not increase
further during the CPT, suggestive of limited further vasoconstrictor reserve (Figures 3 and 4 solid lines a and b). These
subjects had the largest reductions in orthostatic tolerance in
the hypovolemic condition (Figure 3, cumulative stress index
for a and b). One female subject had dramatic increases in
MSNA but only small increases in TPR during the CPT under
both conditions (Figures 3 and 4 solid line c), which indicates
a disassociation between sympathetic activity and the increase in peripheral vascular resistance and suggests a limited
maximal vascular resistance that was mediated by adrenergic

Figure 3. Individual and mean MSNA burst frequency responses
to HUT and CPT⫹HUT. Solid lines (a, b, and c) are from 3 individual subjects. Subjects a and b had limited sympathetic neural
reserve, and their orthostatic tolerance decreased significantly in
hypovolemic condition. Subject c had dissociation between
sympathetic activity and increase in peripheral vascular resistance during CPT in upright position and had limited vasoconstrictor reserve, and orthostatic tolerance was also decreased in
hypovolemic condition. CSI indicates cumulative stress index.
Grouped values are mean⫾SE. **P⬍0.01 compared with supine;
#P⬍0.05 and ##P⬍0.01 compared with normovolemia.

activity. The time to presyncope during the orthostatic tolerance test was decreased prominently in the hypovolemic
condition in this subject. Her data were excluded from the
linear regression analysis shown in Figure 5 because they
were clearly outliers.

Discussion
The major findings from this study are that (1) application of
the CPT in upright tilt increased MSNA and TPR in some
subjects; (2) the time to presyncope from ⫺50 mm Hg LBNP
(equivalent to 60° HUT alone) during the orthostatic tolerance test was positively correlated with an index of neural
sympathetic reserve, that is, the changes in MSNA from HUT
to the CPT during tilting; (3) those who had greater increases
in MSNA also had greater increases in TPR during the CPT
and longer time to presyncope during progressive LBNP; and

Figure 4. Individual and mean TPR responses to HUT and
CPT⫹HUT. Solid lines (a, b, and c) are from 3 individual subjects. Grouped values are mean⫾SE. **P⬍0.01 compared with
supine; #P⬍0.05 and ##P⬍0.01 compared with normovolemia.
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available for vasoconstriction and may determine which
individuals will develop orthostatic intolerance during hypovolemic conditions, such as bed rest or space flight.

Individual Variability in Orthostatic Intolerance

Figure 5. Correlation between time to presyncope from
⫺50 mm Hg LBNP (equivalent to 60° HUT alone) during orthostatic tolerance test and changes in MSNA from 60° HUT to
CPT in HUT under both normovolemic (䢇) and hypovolemic (䡬)
conditions.

(4) 1 subject had a disassociation between the increase in
MSNA and the increase in TPR during the CPT, which
suggests a limited maximal vascular resistance that was
mediated by adrenergic activity. Thus, our results support the
hypothesis that individual variability in orthostatic tolerance
is dependent on the degree of neural and vasomotor reserve

Downloaded from http://ahajournals.org by on May 10, 2022

The individual variability in the development of orthostatic
intolerance after conditions such as space flight and bed rest
is large, but the underlying mechanisms are unclear. Although certain individual physical and physiological factors
(ie, height and resting arterial pressure), and physiological
changes induced by simulated or real microgravity (ie,
hypovolemia, changes in cardiac distensibility, and cardiovascular regulation by the autonomic nervous system) have
been proposed to contribute to the occurrence of orthostatic
intolerance,25–27 no predicting factor has been identified.
The susceptibility to orthostatic intolerance differs among
astronauts returning to Earth, and some differences have been
found between those who did and did not complete a
10-minute stand test after spaceflight.28,29 For instance, it was
observed that the postural vasoconstrictor response was
significantly smaller in astronauts who could not complete
the stand test than in those who could.29 Similarly, the
occurrence of orthostatic intolerance after bed rest varies
from individual to individual and has been reported to be
associated with a lack of augmentation of the increase of TPR
during orthostatic stress.30 Additionally, diminished vascular
resistance responses during orthostatic challenges have been
shown in many patients with neurally mediated syncope well
before the onset of syncope.13,31–33 It has also been reported
that administration of midodrine (␣1-agonist drug) at the end
of bed rest significantly ameliorated the excessive decreases
in blood pressure and presyncope during a provocative tilt
test34 and that enhancement of sympathetic tone by yohimbine (an ␣2-antagonist) markedly improved orthostatic tolerance in patients with neurally mediated syncope.35 Taken
together, these results indicate that vasoconstrictor capacity
may be a contributor to the individual variability in orthostatic intolerance.

Vasoconstrictor Reserve and Orthostatic Tolerance

Figure 6. Comparisons of changes in TPR produced by CPT in
upright tilt (A) and time to presyncope during orthostatic tolerance test (B) in subjects with large sympathetic reserve (ie,
increases in MSNA ⬎5 bursts/min produced by CPT) and small
sympathetic reserve (ie, increases in MSNA ⱕ5 bursts/min produced by CPT). Grouped values are mean⫾SE. Comparisons
were made with unpaired t tests. *P⬍0.05, subjects with large
vs small changes in MSNA.

The present study is the first to demonstrate directly a clear
link between the vasoconstrictor reserve and orthostatic
tolerance in healthy individuals. Our data showing a significant positive correlation between changes in MSNA and TPR
produced by CPT in the upright position and time to presyncope during the orthostatic tolerance test support the assumptions that each human individual may have an intrinsic,
limited reserve for sympathetically mediated vasoconstriction
and that vasoconstrictor reserve could affect the maintenance
of orthostatic tolerance.
The mechanisms for the individual differences in vasoconstrictor reserve are unknown; however, factors such as genetic influence or physical fitness may have to be considered.
Wallin et al36 demonstrated that the strength of sympathetic
outflow to muscle is controlled genetically in humans, which
may contribute to the heritability of blood pressure both in
normotensive and hypertensive individuals. Interindividual
differences in resting MSNA are highly reproducible over a
long time37,38; such differences have been proposed to be
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associated with the individual variability in the number of
active vasoconstrictor neurons.39 It was reported that initial
MSNA levels could influence the magnitude of sympathetic
responses to orthostatic challenges,40,41 which suggests that
the potential for maximal sympathoexcitation diminishes
with higher resting activity. A “ceiling effect” may be an
explanation, namely, sympathetic activity simply cannot increase further. Moreover, high levels of sympathetic activity
may completely saturate postsynaptic adrenergic receptors,
leading to maximal levels of smooth muscle constriction.
Further increases in sympathetic activity under such circumstances might not result in more vasoconstriction.
Physical fitness may be another factor underlying the
individual differences in vasoconstrictor reserve. It was found
that exercise training in initially sedentary healthy individuals
decreased resting arterial pressure and TPR.42 However, the
decreases in BP and TPR were proposed to be due to a
decrease in resting renal but not cardiac sympathetic activity
and MSNA.43,44 On the other hand, muscular vasodilatory
capacity was found to increase after exercise training,45 which
might result in an increase in vasoconstrictor reserve. Human
vasoconstrictor reserve, particularly during exercise, is complex, because it is dependent not only on the amount of
available sympathetic vasoconstrictor activity but also on the
amount of competing vasodilator activity that is directed to
vascular beds.14

Assessment of Vasoconstrictor Reserve by CPT
Downloaded from http://ahajournals.org by on May 10, 2022

The CPT has been used as a nonspecific and strong stimulus
to sympathetic neural outflow in humans. It evokes remarkable increases in BP and MSNA with no significant changes
in HR.46,47 The reflex pathway to activate MSNA may
originate from cold nociceptors in the skin that conduct
afferent signals by unmyelinated C-fibers, and the pathway
may involve a central vasomotor center that serves to regulate
MSNA.47,48 It is independent of the baroreflex and is used to
test the efferent limb of the sympathetic arc.49
Whether activation of the skin’s cold nociceptors by the
CPT can interact with the baroreflexes activated by postural
changes in humans has not been determined with certainty;
however, additive rather than potentiating effects on sympathetic activity were found during LBNP in combination with
the CPT.50 Moreover, cardiovascular responses to combined
CPT and static exercise summed additively,51 which indicates
independence of sympathetic excitation by the baroreflex and
somatic pressor reflex mechanisms. Nevertheless, we cannot
exclude completely the possibility that activation of the skin’s
cold nociceptors attenuates sympathetic excitation by the
baroreflexes, because we noticed that MSNA was slightly
suppressed by the CPT during HUT in some subjects,
especially in the hypovolemic condition. Additionally, we
recognize that application of the CPT in upright tilt may not
have elicited maximal sympathetic excitation and vasoconstriction in all subjects in the present study; however, by
assessing the changes in MSNA and TPR produced by the
CPT in upright tilt, it is highly likely that information on
vasoconstrictor reserve could be gained.
In summary, the present study demonstrates that each
human may have an intrinsic, limited reserve for sympathet-

ically mediated vasoconstriction, and the individual variability in orthostatic tolerance is dependent on the degree of
neural and vasomotor reserve available for vasoconstriction.
Our results suggest that vasoconstrictor capacity may be a
contributor to orthostatic intolerance in humans. It is likely
that vasoconstrictor reserve is one of the mechanisms underlying individual variability in orthostatic tolerance.

Acknowledgments
This study was supported in part by the American Heart Association
Texas Affiliate Postdoctoral Fellowship grant (No. 0225017Y) and
the Wallace, Barbara, and Kelly King Foundation trust. The authors
thank Emily Martini and M. Dean Palmer for expert technical
assistance and Kimberly Williams and Marta Newby for skillful
nursing help.

References
1. Levine BD, Buckey JC, Fritsch JM, et al. Physical fitness and cardiovascular regulation: mechanisms of orthostatic intolerance. J Appl Physiol.
1991;70:112–122.
2. Levine BD, Lane LD, Buckey JC, et al. Ventricular pressure-volume and
Frank-Starling relations in endurance athletes: implications for orthostatic
tolerance and exercise performance. Circulation. 1991;84:1016 –1023.
3. Harrison MH. Athletes, astronauts and orthostatic tolerance. Sports Med.
1986;3:428 – 435.
4. Blomqvist CG, Stone HL. Cardiovascular adjustments to gravitational
stress. In: Shepherd JT, Abboud FM, eds. Handbook of Physiology,
Section 2: The Cardiovascular System. Bethesda, Md: American Physiological Society; 1983:1025–1063.
5. Levine BD, Zuckerman JH, Pawelczyk JA. Cardiac atrophy after bed-rest
deconditioning: a non-neural mechanism for orthostatic intolerance. Circulation. 1997;96:517–525.
6. Wallin BG, Sundlof G. Sympathetic outflow to muscle during vasovagal
syncope. J Auton Nerv Syst. 1982;6:287–291.
7. Johnson JM, Rowell LB, Niederberger M, et al. Human splanchnic and
forearm vasoconstrictor responses to reductions in right atrial and aortic
pressures. Circ Res. 1974;34:515–524.
8. Smith ML, Ellenbogen KA, Eckberg DL. Sympathoinhibition and hypotension in carotid sinus hypersensitivity. Clin Auton Res. 1992;2:
389 –392.
9. Van Lieshout JJ, Wieling W, Karemaker JM, et al. The vasovagal
response. Clin Sci Lond. 1991;81:575–586.
10. Hayoz D, Noll G, Passino C, et al. Progressive withdrawal of muscle
nerve sympathetic activity preceding vaso-vagal syncope during
lower-body negative pressure. Clin Sci (Lond). 1996;91(suppl):S50 –S51.
11. Kamiya A, Michikami D, Fu Q, et al. Pathophysiology of orthostatic
hypotension after bed rest: paradoxical sympathetic withdrawal. Am J
Physiol. 2003;285:H1158 –H1167.
12. Levine BD, Pawelczyk JA, Ertl AC, et al. Human muscle sympathetic
neural and haemodynamic responses to tilt following spaceflight.
J Physiol (Lond). 2002;538:331–340.
13. Brown CM, Hainsworth R. Forearm vascular responses during orthostatic
stress in control subjects and patients with posturally related syncope.
Clin Auton Res. 2000;10:57– 61.
14. Schondorf R, Wieling W. Vasoconstrictor reserve in neurally mediated
syncope. Clin Auton Res. 2000;10:53–55.
15. Triebwasser JH, Johnson RL, Burpo RP, et al. Noninvasive determination
of cardiac output by a modified acetylene rebreathing procedure utilizing
mass spectrometer measurements. Aviat Space Environ Med. 1977;48:
203–209.
16. Pawelczyk JA, Levine BD, Prisk GK, et al. Accuracy and precision of
flight systems for determination of cardiac output by soluble gas
rebreathing. Presented at the 12th NASA/AIAA Life Sciences and Space
Medicine Conference, February, 1995, Houston, Tex.
17. Perhonen MA, Zuckerman JH, Levine BD. Deterioration of left ventricular chamber performance after bed rest: “cardiovascular deconditioning”
or hypovolemia? Circulation. 2001;103:1851–1857.
18. Laszlo G. Respiratory measurements of cardiac output: from elegant idea
to useful test. J Appl Physiol. 2004;96:428 – 437.
19. Vallbo AB, Hagbarth KE, Torebjörk HE, et al. Somatosensory, proprioceptive, and sympathetic activity in human peripheral nerves. Physiol
Rev. 1979;59:919 –957.

Fu et al

Neurovascular Mechanism and Orthostatic Tolerance

Downloaded from http://ahajournals.org by on May 10, 2022

20. Nyyssönen K, Parviainen MT. Practical observations and sources of error
in assays plasma catecholamines by HPLC with electrochemical
detection. Clin Chem. 1987;33:1938 –1939.
21. Van Beaumont W. Evaluation of hemoconcentration from hematocrit
measurements. J Appl Physiol. 1972;32:712–713.
22. Iwasaki K-I, Zhang R, Zuckerman JH, et al. Effect of head-down-tilt bed
rest and hypovolemia on dynamic regulation of heart rate and blood
pressure. Am J Physiol. 2000;279:R2189 –R2199.
23. Cui J, Wilson TE, Crandall CG. Baroreflex modulation of muscle sympathetic nerve activity during cold pressor test in humans. Am J Physiol.
2002;282:H1717–H1723.
24. Sundlöf G, Wallin BG. The variability of muscle nerve sympathetic
activity in resting recumbent man. J Physiol (Lond). 1977;272:383–397.
25. Harrison MH, Kravik SE, Geelen G, et al. Blood pressure and plasma
renin activity as predictors of orthostatic intolerance. Aviat Space Environ
Med. 1985;56:1059 –1064.
26. Pavy-Le Traon A, Louisy F, Vasseur-Clausen P, et al. Contributory
factors to orthostatic intolerance after simulated weightlessness. Clin
Physiol. 1999;19:360 –368.
27. Blomqvist CG, Buckey JC, Gaffney FA, et al. Mechanisms of post-flight
orthostatic intolerance. J Gravit Physiol. 1994;1:P122–P124.
28. Fritsch-Yelle JM, Charles JB, Jones MM, et al. Space flight alters
autonomic regulation of arterial pressure in humans. J Appl Physiol.
1994;77:1776 –1783.
29. Buckey JC, Lane LD, Levine BD, et al. Orthostatic intolerance after
spaceflight. J Appl Physiol. 1996;81:7–18.
30. Lacolley PJ, Pannier BM, Cuche JL, et al. Microgravity and orthostatic
intolerance: carotid hemodynamics and peripheral responses. Am J
Physiol. 1993;264:H588 –H594.
31. Sneddon JF, Counihan PJ, Bashir Y, et al. Impaired immediate vasoconstrictor responses in patients with recurrent neurally mediated syncope.
Am J Cardiol. 1993;71:72–76.
32. Thomson HL, Wright KN, Frenneaux MP. Baroreflex sensitivity in
patients with vasovagal syncope. Circulation. 1997;95:395– 400.
33. Thomson HL, Lele SS, Atherton JJ, et al. Abnormal forearm vascular
responses during dynamic leg exercise in patients with vasovagal
syncope. Circulation. 1995;92:2204 –2209.
34. Ramsdell CD, Mullen TJ, Sundby GH, et al. Midodrine prevents orthostatic intolerance associated with simulated spaceflight. J Appl Physiol.
2001;90:2245–2248.
35. Mosqueda-Garcia R, Fernandez-Violante R, Tank J, et al. Yohimbine in
neurally mediated syncope. J Clin Invest. 1998;102:1824 –1830.

2937

36. Wallin BG, Kunimoto MM, Sellgren J. Possible genetic influence on the
strength of human muscle nerve sympathetic activity at rest. Hypertension. 1993;22:282–284.
37. Sundlöf G, Wallin BG. The variability of muscle nerve sympathetic
activity in resting recumbent man. J Physiol (Lond). 1977;272:383–397.
38. Fagius J, Wallin BG. Long-term variability and reproducibility of resting
human muscle nerve sympathetic activity at rest, as reassessed after a
decade. Clin Auton Res. 1993;3:201–205.
39. Macefield VG, Wallin BG. Firing properties of single vasoconstrictor
neurones in human subjects with high levels of muscle sympathetic
activity. J Physiol. 1999;516:293–301.
40. Burke D, Sundlöf G, Wallin BG. Postural effects on muscle nerve sympathetic activity in man. J Physiol (Lond). 1977;272:399 – 414.
41. Schobel HP, Oren RM, Mark AL, et al. Influence of resting sympathetic
activity on reflex sympathetic responses in normal man. Clin Auton Res.
1995;5:71– 80.
42. Iwasaki KI, Zhang R, Zuckerman JH, et al. Dose-response relationship of
the cardiovascular adaptation to endurance training in healthy adults: how
much training for what benefit? J Appl Physiol. 2003;95:1575–1583.
43. Meredith IT, Friberg P, Jennings GL, et al. Exercise training lowers
resting renal but not cardiac sympathetic activity in humans. Hypertension. 1991;18:575–582.
44. Carter JR, Ray CA, Downs EM, et al. Strength training reduces arterial
blood pressure but not sympathetic neural activity in young normotensive
subjects. J Appl Physiol. 2003;94:2212–2216.
45. Martin WH III, Ogawa T, Kohrt WM, et al. Effects of aging, gender, and
physical training on peripheral vascular function. Circulation. 1991;84:
654 – 664.
46. Victor RG, Leimbach WN, Seals DR, et al. Effects of cold pressor test on
muscle sympathetic nerve activity in humans. Hypertension. 1987;9:
429 – 436.
47. Yamamoto K, Iwase S, Mano T. Responses of muscle sympathetic nerve
activity and cardiac output to the cold pressor test. Jpn J Physiol. 1992;
42:239 –252.
48. Schobel HP, Schmieder RE, Hartmann S, et al. Effects of bromocriptine
on cardiovascular regulation in healthy humans. Hypertension. 1995;25:
1075–1082.
49. Johnson RH, Spalding JMK. Disorders of the Autonomic Nervous System.
Oxford, UK: Blackwell Scientific Publications; 1974:33–58.
50. Ebert TJ, Stowe DF, Barney JA, et al. Summated circulatory responses of
thermal and baroreflexes in humans. J Appl Physiol. 1982;52:184 –189.
51. Peikert D, Smolander J. The combined effect of the clod pressor test and
isometric exercise on heart rate and blood pressure. Eur J Appl Physiol
Occup Physiol. 1991;62:445– 449.

